Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study.
about
Immunobiology and immunotherapy in genitourinary malignanciesImmune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?A Perspective of Immunotherapy for Prostate CancerThe promise of immunotherapy in head and neck squamous cell carcinomaNew drugs in prostate cancerMechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerImmunological interactions in radiotherapy-opening a new window of opportunityNovel technologies and emerging biomarkers for personalized cancer immunotherapyEffects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implicationsNovel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapiesOverview of current immunotherapeutic strategies for gliomaRadio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsImmunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsImmune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysisImmune Checkpoint Blockade: A New Paradigm in Treating Advanced CancerImmune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With ImmunotherapyStrategies for combining immunotherapy with radiation for anticancer therapyMetastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapyTherapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advancesImmune Checkpoint Blockade in Cancer TherapyImmunotherapy for prostate cancer: recent developments and future challengesFrom bench to bedside: immunotherapy for prostate cancerCombining radiation and immunotherapy: a new systemic therapy for solid tumors?Radiation meets immunotherapy - a perfect match in the era of combination therapy?Harnessing immunosurveillance: current developments and future directions in cancer immunotherapyTargeting the adaptive molecular landscape of castration-resistant prostate cancerCombination Approaches with Immune-Checkpoint Blockade in Cancer TherapyCombining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System MalignanciesImmunotherapy in metastatic prostate cancerConcepts of immunotherapy for gliomaImmune checkpoint blockade: a common denominator approach to cancer therapyBeyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.Immunological effect of local ablation combined with immunotherapy on solid malignancies.Current clinical trials testing the combination of immunotherapy with radiotherapy.Antibody Therapies in Cancer.Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implicationsNovel targeted therapeutics for metastatic castration-resistant prostate cancer.Immunotherapy for solid tumors--a review for surgeons.Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.Cancer immunotherapy in clinical practice -- the past, present, and future.
P2860
Q26738668-2492B6E0-3A6D-4BB8-A7D3-B3ACF42B1021Q26740601-6A3CFAC7-3220-471F-BFA4-46CA8603A57AQ26741277-D3DCA1C6-C607-4501-B46C-33DE572284AEQ26744433-D69802E1-A9CB-4D6F-B36E-70EEA55AA627Q26745948-D4D39BF2-AB5B-4884-9602-4B1FFF6D2E00Q26766638-00805989-CAB3-4D39-A0B5-B4E113140865Q26767178-2D2C7327-FB03-4B71-ACA7-67EF4B0624EFQ26770780-B00F0783-ACB3-45EF-8B89-C3384E69D90BQ26774934-0302C5DE-D6A8-4B60-8F6E-4E96EFDC94C6Q26775388-09502D83-6052-411E-B667-78AC93A53543Q26776345-BE880AC4-3F2F-4317-BABE-5E41DB3D55C9Q26779221-B646A184-9EE0-4CDF-9B69-C73BE78AD521Q26781538-0C04FD45-AE7B-4FE4-91C4-D3AC4DD1D42EQ26785746-E9ECF6C4-0EB5-40DF-8C07-9EB4C939A789Q26795509-5300FC3B-488E-4F8D-9EF8-305BB9EB0983Q26796309-02939F42-76FD-4C07-9113-D6A0D78A698BQ26796675-83462E70-BE78-4405-843A-46DF5E62F597Q26825053-50CF8B8B-2F26-41BF-A57A-2E72BFD0643CQ26827475-77DE26CE-DC5D-4895-A5CC-EAD307B93DD0Q26830509-E7300AC7-FD15-4F85-945A-B5E735BBD89BQ26852388-1C684703-240C-4322-8858-A11BAB498F94Q26864390-2AEE8581-D82A-4CB1-ACD2-8993C69F66F2Q26991721-2BA243C8-B99F-45B7-8B78-2EFD5AFDFC46Q27005913-BB912427-E49A-4261-BDD4-59AD6261BBEBQ27021570-B2DD7D7C-E2D5-401D-BC11-E642126B2CD8Q27022821-BADD3723-1DFC-4156-9D80-C6B58BF75326Q28066199-8721E2CA-6F1A-4B96-B803-B853A10AF7BDQ28072007-84F940FC-578C-4A11-B201-EEAAB970F532Q28072081-F503F1C2-4CBD-4676-88AC-3FA6157F53EEQ28083888-61D027B0-2BE0-44DF-9420-29B06B15008DQ28083981-943A2687-28AF-401E-B9B3-99114BFE5B51Q30276874-1D21C275-B4A4-487B-9D22-77BC41B1434DQ30354580-AE4B7EEC-7808-4055-8C90-A4BC515AE05EQ30356447-DE75EF3F-98C1-45CE-8C3B-AADE5ECE3DCAQ31104000-4124D70B-CFF6-417C-9C5D-D11DAA9DD1A2Q33621393-B3EBD223-AFE3-4FBD-9EC5-7C1102FC9EC4Q33642278-69F4F41C-C276-425E-860D-E00C1D079FAEQ33709232-2E740375-F75E-404F-8D8A-2F739DC32EF8Q33930593-BF32A87F-4B4A-48EA-9770-1E1F50EBEA78Q34309399-0B448C9B-CF37-4D1D-B848-A36AF793D53B
P2860
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Ipilimumab alone or in combina ...... multicenter phase I/II study.
@en
type
label
Ipilimumab alone or in combina ...... multicenter phase I/II study.
@en
prefLabel
Ipilimumab alone or in combina ...... multicenter phase I/II study.
@en
P2093
P2860
P921
P356
P1433
P1476
Ipilimumab alone or in combina ...... multicenter phase I/II study.
@en
P2093
A Harzstark
C S Higano
J J Alumkal
M B McHenry
S F Slovin
P2860
P304
P356
10.1093/ANNONC/MDT107
P577
2013-03-27T00:00:00Z